Back to Journals » Drug Design, Development and Therapy » Volume 13
Review
Quizartinib (AC220): a promising option for acute myeloid leukemia
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
12,120 | Dovepress* | 9,594+ | 1,744 | 11,338 | |
PubMed Central* | 2,526 | 742 | 3,268 | ||
Totals | 12,120 | 2,486 | 14,606 | ||
*Since 8 April 2019 |
View citations on PubMed Central and Google Scholar